SPINK1 is a Potential Diagnostic and Prognostic Biomarker for Sepsis
Dexiu Chen,Zhangjing Shi,Xiaolan Gao,Yuxiang Yang,Xianying Lei,Yingchun Hu
DOI: https://doi.org/10.2147/idr.s440117
2024-03-08
Infection and Drug Resistance
Abstract:Dexiu Chen, 1 Zhangjing Shi, 1 Xiaolan Gao, 1 Yuxiang Yang, 1 Xianying Lei, 1, &ast Yingchun Hu 2, &ast 1 Department of Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China; 2 Department of Emergency Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yingchun Hu, Department of Emergency Medicine, The Affiliated Hospital, Southwest Medical University, 25 Taiping Street, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China, Tel +86-830-3165851, Email Xianying Lei, Department of Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 25 Taiping Street, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China, Tel +86-830-3165527, Email Purpose: There are no satisfactory diagnostic biomarkers for sepsis. Accordingly, this study screened biomarkers valuable for sepsis diagnosis and prognosis using data-independent acquisition (DIA) combined with clinical data analysis. Patients and Methods: Serine protease inhibitor Kazal-type 1 (SPINK1) is a differentially expressed protein that was screened using DIA and bioinformatics in sepsis patients (n = 22) and healthy controls (n = 10). The plasma SPINK1 levels were detected using an enzyme-linked immunosorbent assay (ELISA) in an expanded population (sepsis patients, n = 52; healthy controls, n = 10). The diagnostic value of SPINK1 in sepsis was evaluated using receiver operating characteristic (ROC) curve analysis based on clinical data. The prognostic value of SPINK1 for sepsis was evaluated using correlation and survival analyses. Results: DIA quality control identified 78 differential proteins (72 upregulated and six downregulated), among which SPINK1 was highly expressed in sepsis. The ELISA results suggested that SPINK1 expression was significantly elevated in the sepsis group (P < 0.05). ROC analysis of SPINK1 yielded an area under the curve (AUC) of 0.9096. Combining SPINK1 with procalcitonin (PCT) for ROC analysis yielded an AUC of 1. SPINK1 expression was positively correlated with the Sequential Organ Failure Assessment (SOFA) score (r = 3497, P = 0.0053) and APACHE II score (r = 3223, P = 0.0106). High plasma SPINK1 protein expression was negatively correlated with the 28-day survival rate of patients with sepsis (P = 0.0149). Conclusion: The plasma of sepsis patients contained increased SPINK1 protein expression. Combining SPINK1 with PCT might have a high diagnostic value for sepsis. SPINK1 was associated with the SOFA score, APACHE II score, and the 28-day survival rate in patients with sepsis. Keywords: serine protease inhibitor Kazal-type 1, sepsis, DIA, PCT, biomarker Sepsis is a severe condition characterized by dysfunctional organ systems resulting from an imbalanced immune response to infection. Sepsis presents a significant medical and healthcare challenge globally, leading to a mortality rate of approximately one-third to one-sixth of affected individuals. Timely recognition and intervention in sepsis cases substantially decrease patient mortality. 1 However, the current screening methods utilized for early detection, including the Systemic Inflammatory Response Syndrome (SIRS) criteria, quick Sequential Organ Failure Score (qSOFA), and SOFA criteria, are subject to limitations. A high-sensitivity and high-specificity screening tool is currently lacking. 2–4 Pursuing effective sepsis biomarkers is necessary to determine the presence of bacterial infection and the severity of the patient's condition. Such biomarkers would enable the prompt initiation of appropriate treatment during the early disease stages. 5 Scientists are conducting extensive research on sepsis biomarkers involving a wide range of humoral innate immune responses, cytokines, and chemokines, such as C-reactive protein (CRP), serum amyloid P component (SAP), and pentraxin 3 (PTX-3). 6 Additionally, many non-coding RNAs, such as microRNA (miR)-1, miR-124, and miR-34a, are useful as sepsis biomarkers. 7 However, these markers need to be further confirmed by more clinical studies, and the most clinical studies are currently on procalcitonin (PCT). PCT is a precursor to the hormone calcitonin, which is not detectable in healthy conditions. It begins to rise within 3–4 hours after infection, peaking around 24 hours, and has a half-life of 22–35 hours. Consequently, PCT is widely regarded as a reliable indicator of the body's response to infection. However, clinical -Abstract Truncated-
pharmacology & pharmacy,infectious diseases